
Metformin (500mg) + Gliclazide (80mg)
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.
Medical applications
Metviron GZ Tablet is a fixed-dose combination product containing Gliclazide (80mg) and Metformin (500mg). This oral antidiabetic medication is indicated for the treatment of type 2 diabetes mellitus, particularly in patients who are inadequately controlled by monotherapy or as combination therapy with insulin. Gliclazide, an sulfonylurea derivative, enhances insulin release and sensitizes peripheral tissues to insulin, thereby improving glucose tolerance. Metformin, a biguanide, reduces glucose production in the liver and increases glucose uptake in the periphery, thereby reducing blood glucose levels. The combination of Gliclazide and Metformin provides a balanced approach to glucose regulation, offering improved glycemic control and reduced risk of hypoglycemia. In clinical trials, Metviron GZ Tablet demonstrated efficacy in reducing HbA1c levels and improving fasting plasma glucose concentrations, with a favorable safety profile and minimal risk of adverse effects. As with all medications, Metviron GZ Tablet should be used under the guidance of a healthcare provider and in accordance with established treatment guidelines.
How to use Metviron GZ Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metviron GZ Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Metviron GZ Tablet.
High Risk
Metviron GZ Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Metviron GZ Tablet should be used with caution in patients with liver disease. Dose adjustment of Metviron GZ Tablet may be needed. Please consult your doctor. Metviron GZ Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Metviron GZ Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Metviron GZ Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metviron GZ Tablet may be needed. Please consult your doctor. Use of Metviron GZ Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Metviron GZ Tablet

Gliclazide (80mg) + Metformin (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Gliclazide stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues.
Medical applications
Metviron GZ Tablet is a fixed-dose combination product containing Gliclazide (80mg) and Metformin (500mg). This oral antidiabetic medication is indicated for the treatment of type 2 diabetes mellitus, particularly in patients who are inadequately controlled by monotherapy or as combination therapy with insulin. Gliclazide, an sulfonylurea derivative, enhances insulin release and sensitizes peripheral tissues to insulin, thereby improving glucose tolerance. Metformin, a biguanide, reduces glucose production in the liver and increases glucose uptake in the periphery, thereby reducing blood glucose levels. The combination of Gliclazide and Metformin provides a balanced approach to glucose regulation, offering improved glycemic control and reduced risk of hypoglycemia. In clinical trials, Metviron GZ Tablet demonstrated efficacy in reducing HbA1c levels and improving fasting plasma glucose concentrations, with a favorable safety profile and minimal risk of adverse effects. As with all medications, Metviron GZ Tablet should be used under the guidance of a healthcare provider and in accordance with established treatment guidelines.
How to use Metviron GZ Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Metviron GZ Tablet is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Metviron GZ Tablet.
High Risk
Metviron GZ Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Metviron GZ Tablet should be used with caution in patients with liver disease. Dose adjustment of Metviron GZ Tablet may be needed. Please consult your doctor. Metviron GZ Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Metviron GZ Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Metviron GZ Tablet should be used with caution in patients with kidney disease. Dose adjustment of Metviron GZ Tablet may be needed. Please consult your doctor. Use of Metviron GZ Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Metviron GZ Tablet













